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Diacerein, an anti-inflammatory drug used in the 
treatment of osteoarthritis. Being a BCS class II drug, it has poor 
solubility, dissolution rate, and other physicochemical properties. 
Thus the aim of present study was to prepare co-crystals of 
diacerein to improve solubility and dissolution rate. The diacerein 
co-crystals were prepared using urea and tartaric acid as 
conformer by Solvent drop grinding method. The diacerein co-
crystals were characterized by scanning electron microscopy 
(SEM), Fourier Transform Infrared Spectroscopy (FT-IR), 
Differential scanning calorimetry (DSC) and X-ray diffractometry 
(XRD). The co-crystals were evaluated for solubility, dissolution 
rate, and other physicochemical properties and compared with 
commercial diacerein. The co-crystals exhibit the difference in 
the size and shape of crystals. The FT-IR spectra of diacerein co-
crystals showed slightly different in the characteristic peaks 
compared to commercial diacerein sample. DSC data indicate the 
decrease in the melting endotherm of co-crystals compares to 
diacerein. The co-crystals with urea showed an increase and 
intense peak and co-crystals with tartaric acid showed decreased 
number of peaks compared to commercial diacerein. The co-
crystals of diacerein formulated into the Tablet and evaluated for 
tablet properties. The tablet formulation showed improved tablet 
characteristics as well as dissolution rate compared to 
commercial diacerein. 
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INTRODUCTION 
Crystal habit and internal structure of a 
drug can affect bulk and physicochemical 
properties, which range from the flowability to 
chemical stability. Crystals are characterized by 
the repetitious spacing of constituent atoms or 
molecules in a three-dimensional array, whereas 
amorphous forms have atoms or molecules 
randomly placed as in a liquid. Crystallization is 
a spontaneous arrangement of particles to a 
repetitive ordered array i.e. regular geometrical 
pattern (Subrahmanyam et al., 2000). When 
applied solid the adjective crystalline, implies an 
ideal crystal in which structural units termed 
unit cells are repeated regularly and indefinitely 
in three dimensions in a space (Vippagunta et 
al., 2001). An ideal crystal is constructed by the 
regular spatial repetition of identical structural 
units (Saifee et al., 2009) Crystal form can be 
crucial to the performance of dosage form 
(Hickey et al., 2007) 
Over the last decade, there has been 
growing interests in the design of 
pharmaceutical co- crystals, which has emerged 
as a potential method for enhancing the 
bioavailability of drug with low solubility 
(Bittain et al., 2006). To start with, it is 
necessary to important definitions: co-crystal 
and pharmaceutical co- crystals. Co-crystal can 
be defined in a number of ways. A restrictive 
definition utilized by that co-crystals are 
structurally homogenous crystalline materials 
containing two or more components present in 
definite stoichiometric amounts. The co-
crystals components are discrete neutral 
molecular reactants which are solid at ambient 
temperature (Gagniere et al., 2009). Based on 
this definition of co-crystal,  a   pharmaceutical  
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co- crystal means co- crystals with one of the 
co-crystal components as an Active 
Pharmaceutical Ingredient (API) and other 
components are called conformers. From these 
definitions, it is clearly shown that an API 
hydrate is not co-crystal; however solid-state 
API hydrate can cocrystallized with a solid 
conformer to form co-crystal (Lachman et al., 
1991). Co-crystal represents a class of compound 
which offers huge opportunities for the 
pharmaceutical industry (Yadav et al., 2012). 
Diacerein, an anti-inflammatory drug used in 
the treatment of osteoarthritis. Being a BCS 
class II drug, it has poor solubility, dissolution 
rate, and other physicochemical 
properties.Thus project had focused on the 
improvement of physicochemical properties of 
diacerein by co-crystal techniques.                
 
MATERIALS AND METHODS 
Diacerein obtained as a gift sample from 
Lupin Pharmaceutical Ltd, Mumbai, India. 
Urea and tartaric acid were purchased from SD 
Fine Chemical Mumbai. All the solvents used 
are of analytical grade and purchased from 
Qualigens, Mumbai. 
 
Preparation of co-crystal 
Co-crystal prepared with urea as coformer 
Pharmaceutical co-crystal of diacerein 
was prepared with different co-formers using 
solvent drop grinding methods. Diacerein-Urea 
co-crystal was prepared by grinding diacerein 
and urea in 1:1 molar ratio in a pestle and 
mortar for 90min with the addition of few 
drops of ethanol (approximately 10% of 
weight). The solid powder was then scratched 
from walls of mortar and stored in a container ( 
Maski et al., 2009).  
 
Co-crystal prepared with tartaric acid 
as coformer 
Pharmaceutical co-crystal of diacerein 
was prepared with different co-formers using 
solvent drop grinding methods. Diacerein-
Tartaric acid co-crystal was prepared by 
grinding diacerein and urea in 1:1 molar ratio in 
a pestle and mortar for 90min with the addition 
of few drops of ethanol (approximately 10% of 
weight). The solid powder was then scratched 
from walls of mortar and stored in container  
( Maski et al., 2009). 
Micromeritic properties of co-crystal 
Melting point 
To determine the melting point of a co-
crystal, a small amount of the sample is placed 
into a thin-walled capillary tube that is sealed at 
one end. The capillary tube is inserted into a 
melting point apparatus in which the 
temperature can be measured when heated 
(Deshmukh et al., 2010). 
 
Angle of repose 
It was determined by fixed funnel 
method. Accurately weighed quantity (5gm) of 
the sample was taken in a funnel; the height of 
the funnel is adjusted such that the tip of the 
funnel just touches the apex of the heap of the 
blend. Then the drug is allowed to flow 
through the funnel freely onto the surface. The 
diameter is then measured and angle of repose 
was calculated by following equation 
(Deshmukh et al., 2010). 
 
Tan θ = h/r  
 
Where θ is the angle of repose, h is the height 
of the cone and r is the radius of the cone base. 
 
Bulk density 
 It was determined by pouring a weighed 
quantity (5gm) of the sample in to a graduated 
cylinder. The cylinder was dropped at 2s 
interval on hard wood surface three times from 
the height of one inch. It was then calculated 
by the equation given below (Deshmukh et al., 
2010). 
 
Bulk density = 




It was determined by pouring a sample 
(5gm) in a measuring cylinder. The cylinder was 
dropped at 2s interval on hard surface 100 
times from the height of 1 inch. Then the final 
volume occupied by the drug was measured 
(Deshmukh et al., 2010). 
 
Tapped density = 




The compressibility index (Carr’s index) 
is a measure of a powder to be compressed. 
 
Carr’s compressi-
bility index = 
tapped density- bulk density 
× 100 
tapped density 
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Hausner ratio 
The Hausner ratio of powder was 
calculated according to the equation given 
below. 
Hausner ratio = 
Dt 
Df 
Where, Dt = tapped density,    Df = bulk 
density 
 
Characterization of co-crystal 
Infrared spectroscopy (FTIR) 
The co-crystals of Diacerein and 
commercial sample were scanned and recorded 
in the range of 4000-400cm-1by using an 
Infrared spectrophotometer, (Bruker, Alfa-T, 
Germany). The co-crystal samples were 
triturated with dried potassium bromide using 
mortar and pestle. The mixture after grinding 
into fine powder was kept uniformly in a 
suitable die and compressed into a pellet form 
by using a hydraulic press. The resultant pellet 
was mounted in a suitable holder in the IR 
spectrophotometer.  
 
Differential scanning calorimetry (DSC) 
After calibration, thermograms were 
obtained by heating (5mg) of commercial 
sample and its co-crystals prepared with 
coformer at a constant heating rate of 
10°C/min with chart speed of 20mL/min 
under an atmosphere of nitrogen. The exact 
peak temperatures, melting point and heat of 
fusion were automatically calculated. The 
temperature range for the scan was 20°C to 
400°C for all the samples. 
 
Powder X-ray diffraction spectroscopy 
(PXRD) 
X-ray diffraction pattern of Diacerein 
and its various co-crystals prepared with  
coformer were obtained using the X-ray 
diffractometer (BRUKER D8 ADVANCE, 
Germany) at 40kV, 30mA and a scanning rate 
of 1°/min at the diffraction angle 2θ over the 
range of 10-60°using Cu (as anode) radiation of 
wavelength 1.5406 A°. 
 
Solubility and dissolution study 
Solubility studies 
Solubility of diacerein as well as co-crystal was 
studied in medium such as (distilled water). The 
excess quantity (52.63 mg) of co-crystal was 
added in to glass stopper containing 50 mL of 
the medium at 37±0.5°C for 24h on a magnetic 
stirrer at speed 150rpm. Then the solution was 
filtered using Whatman filter paper no 1. 
Appropriate dilution was made and 
concentration was determined 




Dissolution studies of diacerein as well 
as co-crystal were perform using the USP 
dissolution test apparatus with basket rotating 
at 50rpm using 900mL medium at 37±0.5°C. 
Co-crystal equivalent to 50 mg of diacerein 
were taken and filled in to capsule. The capsule 
was kept in basket & dissolution was carried 
out for 60min and the sample (5mL) was 
withdrawn at 10, 20, 30, 40, 50, 60min interval 
and the same volume was replaced to maintain 
sink condition. The absorbance of solution 
(after filtering through Whatman filter) was 
observed by using UV Spectrophotometer 
(Shimadzu, Japan) at 340nm (Nanajawade et al., 
2012).  
 
Formulation of Co-crystals into Tablet 
Accurately weight quantity of co-crystal 
and various excipients such as lactose 
monohydrate, starch, and talc are properly 
mixed, following addition of magnesium 
sterates as lubricant. The powder mixture was 
subjected to compression in to tablet. 
 
Evaluation of tablet 
Hardness  
The resistance of tablet during shipping 
to breakage, under condition of storage, 
transportation and handling before use depends 
on its hardness. For each formulation, the 
hardness of 3 tablets was determined using the 
Pfizer hardness tester. The tablet was held 
along its oblong axis in between two jaws of 
taster. At this point, reading should be zero 
kg/cm2. Then constant force was applied until 
the tablet fractured. The value at this point was 
noted in kg/cm2.  
 
Friability  
Friability is the measure of tablet 
strength. Electrolab friabilator was used for 
testing the friability. For each formulation, the 
friability of 20 tablets was determined. This test 
subjects a number of tablets to the combined 
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effect of shock abrasion by utilizing the plastic 
chamber which revolves at the speed of 25rpm, 
dropping the tablet to a distance of 6 inches in 
each revolution. A sample of pre-weight 20 
tablets was placed in friabilator which was then 
operated for 100 revolutions i.e. 4min. tablets 
were then dedusted and reweight. A loss of less 
than 1% in weight is generally considered 
acceptable Percent friability (%F) was 
calculated as follows. 
 
% F = 




Weight variation test 
The weight variation test was done by 
taking 20 tablets and weight accurately. The 
average weight of tablet was calculated. 
 
Drug Content 
The drug content was carried out by 
taking 20 tablets and triturate. Take equivalent 
weight of powder (5mg) were dissolved in 5mL 
dimethyl sulfoxide (DMSO) and volume was 
made up to 50mL with water by sonicating for 
15min. The solution was filtered through 
Whatman filter paper no.41. After appropriate 
dilutions with water it was analyzed spectro-




The process of breakdown of a tablet 
into smaller particles is called as disintegration.  
The in-vitro disintegration time of a tablet was 
determined using disintegration test apparatus 
as per I.P. specifications. Place one tablet in 
each of the 6 tubes of the basket.  Add a disc to 
each tube and run the apparatus using distilled 
water maintained at 37±2°C. The assembly 
should be raised and lowered between 28 to 32 
cycles per minute in the distilled water 
maintained at 37±2°C. The time minute taken 
for complete disintegration of the tablet with 
no palpable mass remaining in the apparatus 
was measured and recorded 
 
RESULT AND DISCUSSION 
Preparation of Co-crystal  
Diacerein showed good solubility            
in Dimethyl-sulfoxide. It was practically 
insoluble  in  distilled water, ethanol, methanol,  
chloroform, ethyl acetate, and acetone.  Thus 
co-crystals were prepared by solvent drop 
grinding method using ethanol as a solvent of 
choice because of its easy availability, cheaper 
in cost as well as coformer is soluble. Diacerein 
co-crystal was prepared by simple solvent drop 
grinding method because amongst its other 
methods like Solution co-crystallization, slurry 
conversation, anti solvent addition fails 
formation of co-crystal due to its solubility 
problem hence this method has use for 
formation of co-crystal in presence of co-
former such as Urea, Tartaric acid with 1:1 
molar ratio. The coformer has selected by its 
selection criteria high water solubility, hydrogen 
bond donor & acceptor group. These newly 
formed Co-crystals along with the pure drug 
were subjected to further characterization and 
various evaluation tests such as solubility, 
dissolution, etc. 
The values of micromeritic properties 
were mentioned in the table I. The values 
indicates, that prepared co-crystals showed 
good flowability as well as compressibility.The 
angle of repose of co-crystals prepared with 
urea and tartaric acid showed 27.08±085 and 
28.77±0.586 respectively compared to 
commercial diacerein 36.75±0.303, indicates 
improvement in the flowability. 
The bulk and tapped density value of co-
crystals prepared with urea and tartaric acid 
showed 0.363±0.016, 0.346±0.024 and 
0.436±0.02, 0.423±0.01respectively considered 
to commercial diacerein 0.331±0.012 and 
0.391±0.02 showed good compactibility.The 
Carr’s index and Hausners ratio values also 
supports the flowability and compressibility of 
diacerein. 
 
Characterization of co-crystals 
Infrared spectroscopy 
Characteristic peaks of Diacerein 
appeared at 1417.68cm‐1 (C=C stretching), 
1668.43cm-1 (C=O stretching), 1026.1cm‐1 (C-
O-C stretching) and 1369.46cm-1 (Acidic OH) 
were observed. IR spectra of commercial drug 
when compared with the various Co-crystals of 
Diacerein obtained in the presence of coformer 
shows slight change in their characteristic peaks 
because due to the by donating and accepting 
hydrogen  to  form  the  hydrogen bonding in  
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drug and coformer. These results indicated that 
there is slight interaction between drug and 
coformer when formed as co-crystals,  
 
Differential scanning calorimetry 
All the co-crystals prepared by solvent 
drop  grinding  method  showed   characteristic  
endothermic peak of diacerein. DSC is showed 
usually co-crystal composition of pharma-
ceutical powders, when the co-crystal presents 
different melting points. The thermal behaviour 
of commercial diacerein and co-crystals are 
shown below. The DSC curve showed that 
Diacerein appeared on sharp endothermic peak 
at about 236.0°C corresponding to its melting 
point. However the co-crystals obtained with 
urea and tartaric acid as coformer showed the  
shift of endothermic peak towards lower 
temperature at 133.6°C and 170.2°C respectively. 
Shift of endothermic peak towards lower 
temperature indicates the decrease in the 
melting point of drug in co-crystals. This 
decreased melting point accounts for increased 
solubility of drug. 
Powder X-ray diffraction 
The X-ray diffraction pattern of various 
co-crystalwere studied by X-ray diffractometer. 
The X-ray diffraction pattern of pure drug has 
more number of peaks when compared to 
various co-crystals. XRD spectra of drug-
tartaric acid co-crystal have decreased number 
of peaks but increase in intensity was observed. 
The XRD spectra of drug-urea co-crystal have 
increase in the intensity of peaks. Characteristic 
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1 Pure drug 1417.68 1668.43 1026.13 1369.46 
2 Drug-urea co-crystal 1435.04 1678.07 1157.29 1255.56 




Figure 1. (a)FTIR spectra of pure drug (Diacerine), (b) FTIR spectra of Drug-urea co-crystal, (c)  
FTIR spectra of Drug-TA co-crystal 
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diffraction peaks were observed at 2θ=       
15843 and 16673.  The XRD spectra of           
Pure drug and co-crystals obtained in presence 
of co-crystal coformer exhibited essentially 
similar diffraction patterns (2θ values), 
suggesting that   particles   crystallized   in  the        
presence  of co-coformer by solvent drop co-         
grinding method did not undergo structural 
modification.  
However, the differences in the relative 
intensities of their peaks may be attributed to 
differences in the crystal size and habits of the 
sample, which may be attributed to the 
different solubility of the drug in the media. 








Peak fusion point 
(°C) 
Heat of fusion 
(J/g) 
1 Pure drug 238.5 236.0 36.73 
2 Drug-urea co-crystal 137.5 133.6 129.8 





Figure 2. (a) DSC Thermogram of pure drug (Diacerein), (b) DSC Thermogram of Drug-




Figure 3. (a) XRD Spectra of pure drug (Diacerein), (b)XRD Spectra of Drug-Urea co-
crystal, (c) XRD Spectra of Drug-Tartaric acid co-crystal 
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Solubility studies 
The solubility study showed that the 
pure drug Diacerein was the least soluble 
(2.625µg/mL) and the co-crystals grown             
in presence   of   urea  as  coformer   was  
soluble (21.0µg/mL) with 7.84-fold increase         
in solubility   and   the   co-crystal  in  presence  
of tartaric acid was soluble (13.125µg/mL)  
with 4.80-fold increase solubility, The       
increase in the solubility of co-crystals due            
to melting of coformer which are associated 




The dissolution curves of the different 
co-crystals showed differences in the rate of 
dissolution. The result of dissolution studies    
are presented as percent release vs. time. The 
highest dissolution rate was found for the  
drug-urea co-crystal. The dissolution rate co-
crystal in presence of Urea, Tartaric Acid as 
coformer showed  91.31% and 83.13% 
compared to commercial diacerein 46.88% in 
60min.  
The general appearance of tablets, its 
visual identity and overall elegance is essential 
for acceptability, the shape of all the 
formulation remained off white, smooth, flat 
faced circular and no visible cracks. The 
friability was measured by Roche friabilator           
and was found to be drug-0.453%, Drug-            
urea co-crystal 0.410%, Drug-Tartaric acid co-
crystal 0.443% friability and this parameter 
given the satisfactory mechanical resistance of 
the tablet.  
The entire tablet passed the weight 
variation test as the weight variation was within 
the pharmacopoeias limits of 7.5% of the 
weight. 
Percentage drug contents of prepared 
co-crystals were found to be in the range             
of 98.05±0.95w/w to 99.09±1.01 w/w. 
Disintegration time of tablet formulation was 
found to be in the range 153±1 to 190±3s. 
 
CONCLUSION 
Diacerein co-crystal was successfully 
prepared by solvent drop method. Solubility 
and dissolution rate of co-crystals were  
 
 
Figure 4. Dissolution study of Diacerein co-crystal 













Drug 4.7±0.4 0.453±0.15 Passed 98.23 ± 0.02 190 ± 3 
Drug-urea co-crystal 4.5±0.35 0.410±0.10 Passed 98.05 ± 0.95 182 ± 2 
Drug-T.A co-crystal 5.1±0.55 0.443±0.08 Passed 99.09 ±1.01 153 ± 1 
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markedly increased compared to untreated 
Diacerein. Thus the co-crystals techniques were 
helpful to improve the physicochemical 
properties of Diacerein. 
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